SCHEMBL2487876

SCHEMBL2487876

CS(=O)(=O)c1ccc(CC=NO)cc1

nearest known ligand 0.47

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 2/20 0.45
PTGS2 P35354 2/20 0.41
EPHX1 P07099 1/20 0.40
AKR1C3 P42330 1/20 0.40
GRIN2B Q13224 1/20 0.40
KCNJ1 P48048 1/20 0.38
KCNH2 Q12809 1/20 0.38
EPHX2 P34913 1/20 0.38
NR1H4 Q96RI1 1/20 0.38
DAO P14920 1/20 0.38
TGM2 P21980 1/20 0.38
ALDH1A1 P00352 1/20 0.37
CYP1A2 P05177 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7467878 0.81 CA2 (0.55)
SCHEMBL28830799 0.79 ENPP2 (0.47) ENPP2PTGS2EPHX1AKR1C3EPHX2
SCHEMBL1428902 0.78 ENPP2 (0.48) ENPP2PTGS2AKR1C3KCNJ1KCNH2
SCHEMBL10453221 0.76 ENPP2 (0.42) ENPP2PTGS2AKR1C3DAO
SCHEMBL10453222 0.76 ENPP2 (0.42) ENPP2PTGS2AKR1C3DAO
SCHEMBL10453223 0.76 ENPP2 (0.42) ENPP2PTGS2AKR1C3DAO
SCHEMBL27730326 0.75 ENPP2 (0.45) ENPP2PTGS2EPHX1AKR1C3GRIN2B
SCHEMBL31591064 0.74 IDO1 (0.45) ALDH1A1CYP1A2
SCHEMBL28533247 0.74 IDO1 (0.45) ALDH1A1CYP1A2
SCHEMBL3671622 0.74 IDO1 (0.45) ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108822135-B Synthesis method of nitrogen heterocyclic ring substituted thieno [3, 2-d ] thiazole and derivatives thereof 湘潭大学 2021-02-02 CN claimed
EP-2379542-A1 NOVEL OXIME DERIVATIVES Cadila Healthcare Limited (IN) 2011-10-26 EP disclosed
WO-2010084512-A1 NOVEL OXIME DERIVATIVES CADILA HEALTHCARE LIMITED (IN) 2010-07-29 WO disclosed
WO-2009125434-A2 OXIME DERIVATIVES CADILA HEALTHCARE LIMITED (IN) 2009-10-15 WO disclosed